Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP

Published:2008-02 Issue:2 Volume:26 Page:322-333
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Pu Qian,Brassard Pascal,Javeshghani Danesh M,Iglarz Marc,Webb Randy L,Amiri Farhad,Schiffrin Ernesto L

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference47 articles.

1. From bedside to bench to bedside: role of renin–angiotensin–aldosterone system in remodeling of resistance arteries in hypertension;Schiffrin;Am J Physiol Heart Circ Physiol,2004

2. Reactive oxygen species in vascular biology: implications in hypertension;Touyz;Histochem Cell Biol,2004

3. Workshop: Mechanisms and cardiovascular damage in hypertension;Luft;Hypertension,2001

4. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension;Touyz;Clin Exp Pharmacol Physiol,2003

5. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries;Brassard;Hypertension,2005

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Kids on the Hypertension Block: Novel Agents With New Mechanisms of Action;American Journal of Hypertension;2024-08-14

2. Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation;Clinical Science;2024-06-26

3. Diagnosis and management of resistant hypertension;BMJ;2024-06-19

4. The Natriuretic Peptides for Hypertension Treatment;High Blood Pressure & Cardiovascular Prevention;2021-11-02

5. Targeting Cyclic Guanylate Monophosphate in Resistant Hypertension and Heart Failure: Are Sacubitril/Valsartan and Vericiguat Synergistic and Effective in Both Conditions?;High Blood Pressure & Cardiovascular Prevention;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3